MediciNova $44M Financing To Advance Products To Phase II Sep. 7, 2004 By Karen Carey As it prepares to move three products into Phase II studies, MediciNova Inc. raised $44 million in a Series C round. (BioWorld Today)Read More
MGI's 'Great Day': Deal To Market Dacogen, Two Companies Bought Sep. 2, 2004 By Karen Carey MGI Pharma Inc.'s stock surged nearly 20 percent Wednesday after it announced a marketing deal for SuperGen Inc.'s Dacogen, as well as its plans to acquire two private companies focused on oncology. (BioWorld Today)Read More
